A Network-Biology Led Computational Drug Repurposing Strategy to Prioritize Therapeutic Options for COVID-19

Pankaj Khurana; Rajeev K. Varshney; Aporv gupta

doi:10.2139/ssrn.3894299

ScienceGate Book Chapters

JOURNAL ARTICLE

A Network-Biology Led Computational Drug Repurposing Strategy to Prioritize Therapeutic Options for COVID-19

Pankaj Khurana Rajeev K. Varshney Aporv gupta

Year: 2021 Journal: SSRN Electronic Journal Publisher: RELX Group (Netherlands)

DOI: 10.2139/ssrn.3894299

Get Full-Text PDF Get Analytical Report

Keywords:

Coronavirus disease 2019 (COVID-19) Drug repositioning Repurposing Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 2019-20 coronavirus outbreak Drug Drug discovery Drug approval Medicine Computational biology Computer science Pharmacology Virology Bioinformatics Biology Infectious disease (medical specialty) Internal medicine

Metrics

Cited By

0.00

FWCI (Field Weighted Citation Impact)

Refs

Citation Normalized Percentile

Is in top 1%

Is in top 10%

Topics

Computational Drug Discovery Methods

Physical Sciences → Computer Science → Computational Theory and Mathematics

Genetics, Bioinformatics, and Biomedical Research

Life Sciences → Biochemistry, Genetics and Molecular Biology → Molecular Biology

Cell Image Analysis Techniques

Life Sciences → Biochemistry, Genetics and Molecular Biology → Biophysics

A Network-Biology Led Computational Drug Repurposing Strategy to Prioritize Therapeutic Options for COVID-19

Metrics

Topics

Related Documents

A network-biology led computational drug repurposing strategy to prioritize therapeutic options for COVID-19

Drug repurposing using computational methods to identify therapeutic options for COVID-19

Therapeutic Options for COVID-19: Drug Repurposing of Serine Protease Inhibitor Against TMPRSS2

Designing a Network Proximity-Based Drug Repurposing Strategy for COVID-19

Computational Intelligence in Drug Repurposing for COVID-19